GlaxoSmithKline's Rotarix gets regulatory green light

GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.

Treatments to prevent rotavirus-caused gastroenteritis will soon gain an addition now that a new vaccine has been approved by the Food & Drug Administration.